Daily dose of aspirin 'can help treat bowel cancer'

26 April 2012

New health research has suggested that aspirin can act as a positive form of bowel cancer treatment.

According to the study, which has been published in the British Journal of Cancer, found that a daily dose of aspirin can reduce the chance of dying as a result of the disease by 30 per cent.

The research involved the analysis of 4,500 patients from the Eindhoven Cancer Registry who suffer from bowel cancer.

Another interesting statistic was that patients who took aspirin for any length of time after being diagnosed with the disease had a 23 per cent less probability of dying than those who did not use aspirin at all.

Dr Gerrit-Jan Liefers, the study's author, commented: "Bowel cancer is more common in older people so these results could be a big advance in treatment of the disease, particularly in this group. But we need further research to confirm this."

These findings could prove beneficial in Britain, after Cancer Research UK reported that there were more than 41,000 new cases of bowel cancer recorded across the country in 2009 alone.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)